Our customers save time, cost and human resource when synthesis, screening and testing, with results up to:
0
Fewer compounds synthesised
0
Less potency screening
0
Less in vivo testing
Trusted by top biopharma companies
Thousands of med chemists from global drug discovery companies, including 50% of the top biopharma, trust StarDrop to accelerate time from hit to candidate.
StarDrop case studies
Southern Research Institute
Improving anti-inflammation agents with StarDrop's predictive models
adMare Bioinnovations
Supporting Canadian chemistry pioneers with fast SAR analysis
Novalix
Accelerating early-stage drug discovery by connecting multidisciplinary teams
Cerella case studies
BioPharmics case study
Bristol Myers Squibb
From macrocyclic lead to clinical candidate with potential 90% reduction in synthesis requirements
Read moreBook a demo with one of our scientists
Discover how Optibrium’s comprehensive in silico platform can boost the speed, efficiency, and productivity of your chemistry discovery programmes.
Five of the world’s top ten pharma and biotech companies trust Optibrium to power their discovery workflows.